A carregar...
Design of the Redefining Therapy in Early COPD Study
Redefining Therapy in Early COPD (RETHINC) is a 12-week multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of indacaterol/glycopyrrolate 27.5/15.6 mcg inhaled twice daily in symptomatic current and former smokers with respiratory symptom...
Na minha lista:
| Publicado no: | Chronic Obstr Pulm Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
COPD Foundation Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883914/ https://ncbi.nlm.nih.gov/pubmed/32989941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.7.4.2020.0157 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|